Chronic Heart Failure
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 65 years or older who are admitted to a participating hospital in Japan or Korea due to chronic heart failure 2. Patients whose clinical condition has stabilized after acute treatment and who are deemed eligible for assessment by both the attending physician and physical therapist 3. Patients who are judged to be capable of undergoing frailty and sarcopenia assessments safely during hospitalization 4. Patients (or legal representatives) who provide written informed consent after receiving sufficient explanation of the study
Exclusion criteria
Exclusion criteria: 1. Patients for whom clinical assessment is deemed inappropriate due to acute myocardial infarction or other serious acute illnesses 2. Patients with severe dementia or impaired communication making it difficult to conduct evaluation or obtain informed consent 3. Patients with physical conditions that prevent the safe implementation of muscle function or basic mobility assessments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Prevalence of frailty in older patients with chronic heart failure in Japan and Korea 2. Prevalence of sarcopenia in the same population 3. Prevalence of coexisting frailty and sarcopenia 4. Incidence of hospital-associated disability(HAD) at the time of hospital discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Readmission rates within 30, 90, and 180 days after hospital discharge 2. Mortality rates within 30, 90, and 180 days after hospital discharge 3. Impact of coexisting frailty and sarcopenia on these readmission and mortality outcomes | — |
Countries
Japan,Asia(except Japan)
Contacts
Wakayama Professional University of Rehabilitation Department of Physical Therapy